GlassScriptPhysician profile
Kaitlyn Jones
NPI 1417555459
$7,879.56
in general payments reported to CMS, 2019-2025
29 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,664 · 2022: $2,628 · 2023: $1,996 · 2024: $1,087 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,321 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,321.12 |
| Education | $266.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,516.53 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $946.43 | 2021-2025 | Ilumya, Winlevi, Absorica Ld |
| Regeneron Healthcare Solutions, INC. | $563.07 | 2021-2024 | Dupixent |
| Incyte Corporation | $521.35 | 2021-2024 | Opzelura |
| Genzyme Corporation | $509.59 | 2021-2024 | |
| Janssen Biotech, INC. | $427.21 | 2021-2024 | Tremfya |
| Leo Pharma INC. | $342.34 | 2021-2025 | Adbry, Anzupgo |
| Amgen INC. | $316.60 | 2021-2024 | Otezla |
| Galderma Laboratories, L.P. | $312.43 | 2021-2024 | Aklief |
| Novartis Pharmaceuticals Corporation | $288.81 | 2022-2024 | |
| Lilly USA, LLC | $285.42 | 2021-2024 | Olumiant, Taltz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $243.36 | 2021-2024 | Arazlo, Jublia |
| Pfizer INC. | $240.37 | 2021-2023 | |
| Ucb, INC. | $205.14 | 2021-2024 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $196.38 | 2024 | Zoryve |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $189.42 | 2022-2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $119.27 | 2025 | |
| Allergan, INC. | $107.17 | 2021 | |
| Almirall LLC | $105.40 | 2021-2023 | Klisyri, Seysara |
| Journey Medical Corporation | $90.47 | 2022-2023 | |
| Epi Health, LLC | $88.36 | 2021-2022 | |
| Genentech USA, INC. | $78.03 | 2022-2024 | Erivedge, Xolair |
| Mayne Pharma Commercial LLC | $49.90 | 2021-2023 | |
| Revance Therapeutics, INC. | $39.20 | 2025 | Daxxify |
| Dermavant Sciences, INC. | $33.63 | 2023 | Vtama |
| Convatec INC. | $20.72 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $15.65 | 2024 | Sotyktu |
| Dermira, INC. | $14.40 | 2021 | |
| Organogenesis INC. | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.